Objective: Our objective was to investigate the paradoxical response and the factors responsible for such an uncommon (but known) response to chemotherapy in neurotuberculosis. Material and Methods: Ten children with intracranial tuberculomas/neurotuberculosis were retrospectively studied, who were on regular antituberculous chemotherapy. Any deterioration of the neurological condition, increase in the size of the lesion or appearance of new lesions was studied clinically and radiologically during the follow-up period. Results: An atypical response to chemotherapy was observed from 3 weeks to 1 year of chemotherapy. Four of the 10 children, who were receiving chemotherapy for either posttubercular meningitis (TBM), hydrocephalus (2) or TBM (2), developed multiple granulomas in 3 and hydrocephalus in 1 case. The remaining 6 children who were diagnosed to have granulomas at their presentation deteriorated at the follow-up despite regular chemotherapy. CT scans were repeated in 7 of 10 cases at the time of neurological deterioration, out of which 5 children showed appearance of new granulomas or abscess(es) and 2 showed an increase in the size of their preexisting granulomas. One patient with faintly enhancing granulomas in the posterior fossa responded to an additional use of steroids. The remaining 9 patients required surgical intervention on account of their neurological deterioration. Conclusions: (1) Paradoxical responses to intracranial tuberculoma/neurotuberculosis can occur at any time even up to 1 year during chemotherapy despite a regular standard antitubercular treatment. (2) New granuloma(s) or abscess(es) may appear in children receiving chemotherapy for TBM during the follow-up. (3) Hydrocephalus may also appear despite a regular chemotherapy in treated TBM cases. (4) Immature faintly enhancing tuberculomas have a more likely chance of resolution with antituberculous chemotherapy and glucocorticoids, while a well-formed and probably large-sized (>3 cm) granuloma may have a risk of paradoxical enlargement.

1.
Hejazi N, Hassler W: Multiple intracranial tuberculomas with atypical response to tuberculostatic chemotherapy. Acta Neurochir (Wien) 1977;139:194–202.
2.
Jain VK, Chandramukhi A, Venkataramana NK, Das VS, Gokul VN: The far cry of TB brain: report of cases of tubercular meningitis, multiple tuberculoma and tubercular abscess. Clin Neurol Neurosurg 1989;91:171–176.
3.
Dastur DK, Manghani DK: Pathology and pathogenetic mechanism in neurotuberculosis. Radiol Clin North Am 1995;33:733–752.
4.
Dastur HM: Tuberculoma; in Vinken PJ, Bruyn GW (eds): Handbook of Clinical Neurology. New York, Elsevier, 1995, vol 18, pp 413–426.
5.
Kumar R: Atypical response to chemotherapy in neurotuberculosis. Br J Neurosurg 1998;12:344–348.
6.
Gropper MR, Schuulder M, Duran HL, Wolansky L: Cerebral tuberculosis with expansion into brain stem tuberculoma. J Neurosurg 1994;81:927–931.
7.
Rammurthi B, Tandon PN: Tuberculosis of CNS; in Tandon PN (ed): Textbook of Neurosurgery, ed 2. New Delhi, Churchill Livingstone, 1996, vol 1, pp 475–488.
8.
Abdul Jabbar M: Paradoxical expansion of intracranial tuberculoma: two case reports from Saudi Arabia. J Trop Med Hyg 1996;94:374–376.
9.
Bouchez B, Arnott G: Paradoxical expansion of intracranial tuberculoma during chemotherapy (letter). Lancet 1984;ii:470–471.
10.
Borah NC, Maheshwari MC, Mishra NK, Goulatia RK: Appearance of tuberculomas during course of tubercular meningitis. J Neurol 1984;231:269–270.
11.
Chambers ST, Hendrickse WA, Record C, Rudge P, Smith H: Paradoxical expansion of tuberculomas during chemotherapy. Lancet 1984;ii:181–183.
12.
Thrush DC, Barwick DD: Three patients with intracranial tuberculomas with unusual features. J Neurol Neurosurg Psychiatry 1974;31:566–569.
13.
Teoh R, Humphries MJ, O’Mahony G: Symptomatic intracranial tuberculoma developing during treatment of tuberculosis: a case report of 10 patients and review of literature. Q J Med 1987;63:449–460.
14.
Rao GP, Nadh BR, Hemaratanan A, Srinivas TV, Reddy PK: Paradoxical progression of tuberculous lesions during chemotherapy of central nervous system tuberculosis. J Neurosurg 1995;83:359–362.
15.
Afghani B, Lieberman JM: Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis 1994;19:1092–1099.
16.
Kumar R, Singh V: Brain stem abscesses in children. J Pediatr Neurol (Turkey) 2004;8:36–40.
17.
William AP Jr: Antimicrobial agents, drugs used in chemotherapy of tuberculosis; in Hardman JG, Limbird LE (eds): Goodman and Gillman Pharmacological Basis of Therapeutics, ed 10. New York, McGraw-Hill, 2001, pp 1281–1291.
18.
Kastrup O, Wanke I, Maschke M: Neuroimaging of infections. Neuro Rx 2005;2:324–332.
19.
Gaviani P, Shwartz RB, Hedley-Whyte ET, et al: Diffusion-weighted imaging of fungal cerebral infection. AJNR Am J Neuroradiol 2005;5:1115–1121.
20.
Rajshekhar: Image guided stereotactic biopsy of supratentorial mass lesions; in Ramamurthi R, Sridhar R, Vasudevan MC (eds): Operative Neurosurgery, ed 1. New Delhi, BI Publication, 2005, vol 1, pp 644–653.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.